Knee Replacement Surgery

3

Review clinical trials related to Knee Replacement Surgery. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty

The goal of this study is to better understand how daily treatment with cannabidiol (CBD) affects the need for opioid pain medication, as well as pain, inflammation and other related symptoms, after knee replacement surgery. The information collected in this study is necessary to help understand whether CBD may be a useful medication before and/or after surgery. The study hypothesis is that CBD exerts opioid-sparing effects through anti-inflammatory, analgesic, and anxiolytic mechanisms.

Participants needed: 380
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Chad BrummettUpdated: Apr 15, 2026Locations: 2
Eligibility criteria

Willing and able to read, understand, and sign the informed consent (English) [+7]

Revision or bilateral total knee arthroplasty [+27]

Status: Not yet recruiting

Effect of Virtual Reality on Patient Outcomes and Satisfaction in Total Knee Replacement

This study aims to evaluate the effectiveness of virtual reality (VR) in managing preoperative anxiety and postoperative pain in patients undergoing total knee replacement. Investigators will assess the impact of preoperative VR training on anxiety levels, explore the effectiveness of relaxing and distracting VR videos for pain management after surgery, and determine the optimal timing for VR application by comparing different VR intervention times. Our goal is to identify how VR can improve both the emotional and physical recovery process for patients undergoing knee replacement surgery.

Participants needed: 64
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Aykut TurgutUpdated: Sep 26, 2025Locations: 1
Eligibility criteria

Patients with an ASA score of 1, 2, or 3 [+2]

Using >30 mg of oral oxycodone or equivalent daily [+10]

Status: Recruiting

Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality

Sleep disturbances are prevalent in older patients with osteoarthrosis or fracture who are scheduled for knee or hip replacement surgery. The occurrence of sleep disturbances is associated with worse outcomes including increased risk of delirium and cardiac events, and worsened functional recovery. Dexmedetomidine is a highly selective α2-adrenergic agonist with sedative, anxiolytic, and analgesic properties. It exerts sedative effects via activating the endogenous sleep pathways and produces a state like non-rapid eye movement sleep, which is different from opioid- and benzodiazepine-induced sedation. Esketamine is a N-methyl-D-aspartic acid receptor antagonist and has been used as an anesthetic and analgesic. Recent studies showed that low-dose esketamine has anti-depressive and sleep-promoting effects. The investigators suppose that mini-dose dexmedetomidine-esketamine combined infusion at night can improve perioperative sleep quality in patients scheduled for knee or hip replacement surgery.

Participants needed: 154
Trial details
Phase: Phase 4Age: 65-90Biological sex: AllType: InterventionalSponsor: Peking University First HospitalUpdated: Jul 30, 2025Locations: 2
Eligibility criteria

Age ≥65 years and <90 years; [+1]

Refuse to participate; [+8]